OTCMKTS:CCELCRYO-CELL International Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CRYO-CELL International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $7.68 0.00 (0.00 %) (As of 07/10/2020 11:29 AM ET) Add Compare Share Today's Range$7.68Now: $7.68▼$7.6850-Day Range$6.55MA: $7.60▼$8.5052-Week Range$4.52Now: $7.68▼$9.00VolumeN/AAverage Volume7,365 shsMarket Capitalization$59.90 millionP/E Ratio24.00Dividend YieldN/ABeta0.08 ProfileAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, kidney, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue specimens worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was founded in 1989 and is headquartered in Oldsmar, Florida.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for CRYO-CELL International. Previous Next 2.3 Community Rank Outperform VotesCRYO-CELL International has received 50 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCRYO-CELL International has received 58 “underperform” votes. (Add your “underperform” vote.)Community SentimentCRYO-CELL International has received 53.70% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CRYO-CELL International and other stocks. Vote “Outperform” if you believe CCEL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CCEL will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCRYO-CELL International does not currently pay a dividend.Dividend GrowthCRYO-CELL International does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CRYO-CELL International insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $165,000.00 in company stock.Percentage Held by Insiders54.03% of the stock of CRYO-CELL International is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 0.86% of the stock of CRYO-CELL International is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of CRYO-CELL International is 24.00, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 16.73.Price to Earnings Ratio vs. SectorThe P/E ratio of CRYO-CELL International is 24.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 29.40. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.79 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:CCEL Previous Symbol CUSIPN/A CIK862692 Webwww.cryo-cell.com Phone813-749-2100Debt Debt-to-Equity RatioN/A Current Ratio1.05 Quick Ratio0.98Price-To-Earnings Trailing P/E Ratio24.00 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$31.80 million Price / Sales1.88 Cash Flow$0.36 per share Price / Cash Flow21.30 Book Value($0.89) per share Price / Book-8.63Profitability EPS (Most Recent Fiscal Year)N/A Net Income$2.29 million Net Margins8.50% Return on Equity-37.99% Return on Assets6.25%Miscellaneous Employees92 Outstanding Shares7,800,000Market Cap$59.90 million Next Earnings Date7/20/2020 (Estimated) OptionableNot Optionable OTC:CCEL Rates by TradingView Receive CCEL News and Ratings via Email Sign-up to receive the latest news and ratings for CCEL and its competitors with MarketBeat's FREE daily newsletter. CRYO-CELL International (OTCMKTS:CCEL) Frequently Asked Questions How has CRYO-CELL International's stock been impacted by COVID-19 (Coronavirus)? CRYO-CELL International's stock was trading at $7.20 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CCEL shares have increased by 6.7% and is now trading at $7.68. View which stocks have been most impacted by Coronavirus. When is CRYO-CELL International's next earnings date? CRYO-CELL International is scheduled to release its next quarterly earnings announcement on Monday, July 20th 2020. View our earnings forecast for CRYO-CELL International. How were CRYO-CELL International's earnings last quarter? CRYO-CELL International, Inc. (OTCMKTS:CCEL) announced its quarterly earnings data on Tuesday, April, 14th. The company reported $0.07 EPS for the quarter. The firm had revenue of $7.62 million for the quarter. CRYO-CELL International had a net margin of 8.50% and a negative return on equity of 37.99%. View CRYO-CELL International's earnings history. Has CRYO-CELL International been receiving favorable news coverage? News articles about CCEL stock have been trending positive this week, according to InfoTrie. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. CRYO-CELL International earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about CRYO-CELL International. Who are some of CRYO-CELL International's key competitors? Some companies that are related to CRYO-CELL International include Lannett (LCI), New Frontier Health (NFH), Five Prime Therapeutics (FPRX), Medicenna Therapeutics (MDNA), Itamar Medical (ITMR), Gritstone Oncology (GRTS), Fortress Biotech (FBIO), TAIWAN LIPOSOME/S (TLC), Ergomed (ERGO), Selecta Biosciences (SELB), CymaBay Therapeutics (CBAY), ICC Labs (ICC), Paratek Pharmaceuticals (PRTK), Fennec Pharmaceuticals (FRX) and Verrica Pharmaceuticals (VRCA). View all competitors. What other stocks do shareholders of CRYO-CELL International own? Based on aggregate information from My MarketBeat watchlists, some companies that other CRYO-CELL International investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Bunge (BG), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), AMAG Pharmaceuticals (AMAG), Ampio Pharmaceuticals (AMPE) and Apellis Pharmaceuticals (APLS). Who are CRYO-CELL International's key executives? CRYO-CELL International's management team includes the following people: Mr. David I. Portnoy, Chairman & Co-CEO (Age 56)Mr. Mark L. Portnoy, Co-CEO & Director (Age 55)Ms. Jill M. Taymans, CFO & VP of Fin. (Age 49)Mr. Oleg Mikulinsky, Chief Information Officer (Age 46)Dr. Merri Buff Mair, Medical Director & Member of Medical & Scientific Team What is CRYO-CELL International's stock symbol? CRYO-CELL International trades on the OTCMKTS under the ticker symbol "CCEL." How do I buy shares of CRYO-CELL International? Shares of CCEL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is CRYO-CELL International's stock price today? One share of CCEL stock can currently be purchased for approximately $7.68. How big of a company is CRYO-CELL International? CRYO-CELL International has a market capitalization of $59.90 million and generates $31.80 million in revenue each year. CRYO-CELL International employs 92 workers across the globe. What is CRYO-CELL International's official website? The official website for CRYO-CELL International is www.cryo-cell.com. How can I contact CRYO-CELL International? CRYO-CELL International's mailing address is 700 Brooker Creek Boulevard Suite 1800, Oldsmar FL, 34677. The company can be reached via phone at 813-749-2100. This page was last updated on 7/10/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
